Stanford Medicine
K

Debate: Is Combination Biologic Therapy for IBD Ready for Primetime?

By Stanford Medicine FEATURING Kian Keyashian, Siddharth Singh
By Stanford Medicine FEATURING Kian Keyashian, Siddharth Singh
0 views
June 13, 2023
Comments 0
Login to view comments. Click here to Login

Recommended

AUTOPLAY
20:02
Cedars Sinai

Monitoring Patients on IBD Therapies: How to Monitor? What Is the Im…

Feat. C. Ha
28:07
UChicago Medicine

Guidelines for Ulcerative Colitis Diagnosis and Management

Feat. D. T. Rubin
34:50
Scripps Health: 2019 Inflammatory Bowel Disease

New Approaches to Diet & Nutrition in IBD

Feat. G. Konijeti
38:58
Northwestern Medicine Gastroenterology

Top Ten Advances in IBD 2023

Feat. S. Hanauer
29:48
Rubin Lab

Advanced UC Drugs & Positioning - November 2023, IBD School (Syd…

Feat. D. T. Rubin
33:16
NYU Langone

Precision Medicine in IBD

Feat. M. Long
26:16
Asher Kornbluth

Positioning Therapies in IBD (audio only)

23:23
Washington University in St. Louis

Positioning Medical Therapy in IBD

Feat. M. Ciorba
32:09
MedStar Georgetown and Northwestern University IBD Masterclass

Goals of Treatment in IBD: Treatment Endpoints and Putting Risks int…

Feat. C. Siegel
30:31
Washington University in St. Louis

Perianal Crohn's Disease: Optimizing the Management with the Pa…

Feat. A. Hart
32:09
University of Colorado Department of Medicine

New and Emerging Treatments for IBD in 2024

Feat. M. Chiorean
22:51
MetroHealth

Management of Pouchitis and Its Complications

Feat. B. Shen
21:04
DDW 2023 Conference Coverage

DDW 2023 Updates and Perspectives: Evolution in Medical Treatments f…

Feat. S. Hanauer
67:28
Rubin Lab

State of the Art Management of IBD: How Should We Sequence Therapies…

Feat. D. T. Rubin
17:20
Houston Methodist Hospital

Complementary Medicine Use in IBD

Feat. M. Irani
22:14
NYU Langone

I Lost Response! Straight to JAK, Switch Biologics, or a Combo Appro…

Feat. L. Malter
23:40
University of Colorado Department of Medicine

New and Emerging Therapies for Inflammatory Bowel Disease

Feat. W. Ahmed
18:26
Washington University in St. Louis

Leukocyte Trafficking Agents in the Management of IBD

Feat. K. Huff-Hardy
21:18
EBMed

Debate: Stride II: Should We Treat to Target or Treat to Symptom Res…

Feat. B. Abraham, A. Charabaty
21:21
Cleveland Clinic - Digestive Disease Institute

S1P Receptor Modulators in IBD - 2023

Feat. M. Regueiro